Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients

Table 1 Demographics for the 114 lung transplant recipients in the study

Characteristics	N = 114
LTx, years	2001-2006
Recipient Age years, mean (range)	49 (10-68)
Female (%)	63
Donor Age years, mean (range)	42 (5-70)
Female (%)	55
CMV serostatus, n (%)	D+/R+: 66 (58)
	D-/R+: 22 (19)
	D+/R-: 17 (15)
	D-/R -: 9 (8)
Tx type n (%)
-Single	80 (70)
-Double	31 (27)
-Heart and lung	3 (3)
Pre-transplant diagnosis (%)
-COPD	38
-IPF	20
-A1AT	18
-CF	6
-PAH + PH	6
-GVHD	3.5
-Scleroderma	3.5
-Eisenmenger syndrome	2
-Others	3

R = recipient, D = donor, COPD = chronic obstructive pulmonary disease, CF = Cystic fibrosis, A1AT = alpha-1 antitrypsin deficiency with emphysema, IPF = idiopathic pulmonary fibrosis, PAH = pulmonary arterial hypertension, PH = pulmonary hypertension, GVHD = graft-versus-host disease.

ISSN: 1471-2334